Invenomic Capital Management »

Regenxbio Inc equity us cm shares owned by Invenomic Capital Management

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by Invenomic Capital Management from 13F filings

Historical chart of Invenomic Capital Management investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by Invenomic Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by Invenomic Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 427k 9.65

More positions owned by Invenomic Capital Management

Ark Etf Tr Innovation Etf Put Option (ARKK)
Global Payments (GPN)
Dentsply Sirona (XRAY)
Ego (EGO)
Viatris (VTRS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Acadia Healthcare (ACHC)
Teleflex Incorporated (TFX)
Ringcentral Cl A (RNG)
Pvh Corporation (PVH)
Concentrix Corp (CNXC)
Akamai Technologies (AKAM)
Sonoco Products Company (SON)
Sensata Technologies Hldg Pl SHS (ST)
Bill Com Holdings Ord (BILL)

View all positions for Invenomic Capital Management

Top funds holding Regenxbio Inc equity us cm

BlackRock
Redmile Group
Jpmorgan Chase & Co
Vanguard Group
State Street Corporation
Goldman Sachs Group
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Integral Health Asset Management
Morgan Stanley
22NW
Assenagon Asset Management
Nuveen
Voss Capital

View all funds holding Regenxbio Inc equity us cm